• Home
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Journal PharmaceuticalIntelligence.com
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2022 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • SOP Web STAT
  • Blockchain Transactions Network Ecosystem
  • Contact Us
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Funding, Deals & Partnerships: BIOLOGICS & MEDICAL DEVICES; BioMed e-Series; Medicine and Life Sciences Scientific Journal – http://PharmaceuticalIntelligence.com

Feeds:
Posts
Comments

Premalata Pati, PhD, PostDoc in Biological Sciences, Medical Text Analysis with Machine Learning

Premalata Pati, PhD, PostDoc in Biological Sciences, Medical Text Analysis with Machine Learning

https://pharmaceuticalintelligence.com/contributors-biographies/postdoctorants-computer-science-pharmaceutical-sciences-biological-sciences/premalata-pati-phd-postdoc-in-pharmaceutical-sciences-medical-text-analysis-with-machine-learning/

1. Publications on Pharmaceuticalintelligence.com

2. Progress on Text Analysis

Sl No.Date Article Name Article URL  
1 July 6, 2021 Yet another Success Story: Machine Learning to predict immunotherapy responsehttps://pharmaceuticalintelligence.com/2021/07/06/yet-another-success-story-machine-learning-to-predict-immunotherapy-response/
2July 2, 2021 The NIH-funded adjuvant improves the efficacy of India’s COVID-19 vaccinehttps://pharmaceuticalintelligence.com/2021/07/02/the-nih-funded-adjuvant-improves-the-efficacy-of-indias-covid-19-vaccine/
3June 20, 2021Non-toxic antiviral nanoparticles with a broad spectrum of virus inhibitionhttps://pharmaceuticalintelligence.com/2021/06/20/non-toxic-antiviral-nanoparticles-with-a-broad-spectrum-of-virus-inhibition/
4June 10, 2021Despite heated discussion over whether it works, the FDA has approved Aduhelm, bringing a new ray of hope to the Alzheimer’s patients.https://pharmaceuticalintelligence.com/2021/06/10/despite-heated-discussion-over-whether-it-works-the-fda-has-approved-aduhelm-bringing-a-new-ray-of-hope-to-the-alzheimers-patients/
5May 27, 2021Renal tumor macrophages linked to recurrence are identified using single-cell protein activity analysishttps://pharmaceuticalintelligence.com/2021/05/27/renal-tumor-macrophages-linked-to-recurrence-are-identified-using-single-cell-protein-activity-analysis/
6May 4, 2021Machine Learning (ML) in cancer prognosis prediction helps the researcher to identify multiple known as well as candidate cancer diver geneshttps://pharmaceuticalintelligence.com/2021/05/04/machine-learning-ml-in-cancer-prognosis-prediction-helps-the-researcher-to-identify-multiple-known-as-well-as-candidate-cancer-diver-genes/
7April 10, 2021Cryo-EM disclosed how the D614G mutation changes SARS-CoV-2 spike protein structure.https://pharmaceuticalintelligence.com/2021/04/10/cryo-em-disclosed-how-the-d614g-mutation-changes-sars-cov-2-spike-protein-structure/
8March 22, 2021Gene Therapy could be a Boon to Alzheimer’s disease (AD): A first-in-human clinical trial proposedhttps://pharmaceuticalintelligence.com/2021/03/22/gene-therapy-could-be-a-boon-to-alzheimers-disease-ad-a-first-in-human-clinical-trial-proposed/
9February 20, 2021Inhibitory CD161 receptor recognized as a potential immunotherapy target in glioma-infiltrating T cells by single-cell analysishttps://pharmaceuticalintelligence.com/2021/02/20/inhibitory-cd161-receptor-identified-in-glioma-infiltrating-t-cells-by-single-cell-analysis-2/

26 June 2021

LPBI Phase 2: Proof of Concept – Cancer Volume 1 – Chapter 12 Completion

Dropbox– Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graphs and PPT

URL: https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Premalata%20Pati/Cancer%2C%20Vol%201%20Chapters%207-12/CHAPTER-12

WORD CLOUDs Uploaded in Articles of Chapter 12

Article 12.1- https://pharmaceuticalintelligence.com/2013/05/15/dna-nanotechnology/

Article 12.2- https://pharmaceuticalintelligence.com/2013/01/09/nanotechnology-personalized-medicine-and-dna-sequencing/

Article 12.3- https://pharmaceuticalintelligence.com/2012/12/09/naotech-therapy-for-breast-cancer/

Article 12.4- https://pharmaceuticalintelligence.com/2013/02/07/prostate-cancer-and-nanotecnology/

Article 12.5- Missing

Article 12.6- https://pharmaceuticalintelligence.com/2012/11/23/nanotechnology-tackles-brain-cancer/

Article 12.7- https://pharmaceuticalintelligence.com/2012/11/08/lung-cancer-nsclc-drug-administration-and-nanotechnology/

LPBI Phase 2: Proof of Concept – Cancer Volume 1 – Chapter 11 Completion

Dropbox– Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graphs and PPT

URL: https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Premalata%20Pati/Cancer%2C%20Vol%201%20Chapters%207-12/CHAPTER-11

WORD CLOUDs Uploaded in Articles of Chapter 11

Article 11.1.1- https://pharmaceuticalintelligence.com/2012/08/27/the-incentive-for-imaging-based-cancer-patient-management/

Article 11.1.2- https://pharmaceuticalintelligence.com/2013/03/10/imaging-biomarkers-is-imaging-based-tissue-characterization/

Article 11.2.1- https://pharmaceuticalintelligence.com/2013/04/10/2013-year-of-the-ultrasound/

Article 11.2.2- https://pharmaceuticalintelligence.com/2012/09/10/imaging-seeing-or-imagining-part-1/

Article 11.2.3- https://pharmaceuticalintelligence.com/2013/05/21/early-detection-of-prostate-cancer-aua-guideline/

Article 11.2.4- https://pharmaceuticalintelligence.com/2012/09/02/todays-fundamental-challenge-in-prostate-cancer-screening-2/

Article 11.2.5- https://pharmaceuticalintelligence.com/2013/01/28/state-of-the-art-in-oncologic-imaging-of-prostate/

Article 11.2.6- https://pharmaceuticalintelligence.com/2013/05/05/from-aua2013-histoscanning-aided-template-biopsies-for-patients-with-previous-negative-trus-biopsies/

Article 11.2.7- https://pharmaceuticalintelligence.com/2013/02/15/on-the-road-to-improve-prostate-biopsy/

Article 11.2.8- https://pharmaceuticalintelligence.com/2013/06/06/ultrasound-imaging-as-an-instrument-for-measuring-tissue-elasticity-shear-wave-elastography-vs-strain-imaging/

Article 11.2.9- https://pharmaceuticalintelligence.com/2012/11/19/what-could-transform-an-underdog-into-a-winner/

Article 11.2.10- https://pharmaceuticalintelligence.com/2013/04/28/ultrasound-based-screening-for-ovarian-cancer/

Article 11.2.11- https://pharmaceuticalintelligence.com/2013/03/22/imaging-guided-cancer-therapy-a-discipline-in-need-of-guidance/

Article 11.3.1- https://pharmaceuticalintelligence.com/2012/10/09/introducing-smart-imaging-into-radiologists-daily-practice/

Article 11.3.2- https://pharmaceuticalintelligence.com/2012/09/29/imaging-seeing-or-imagining-part-2/

Article 11.3.3- https://pharmaceuticalintelligence.com/2012/09/29/imaging-guided-biopsies-is-there-a-preferred-strategy-to-choose/

Article 11.3.4- https://pharmaceuticalintelligence.com/2012/12/16/new-clinical-results-supports-imaging-guidance-for-targeted-prostate-biopsy/

Article 11.3.5- https://pharmaceuticalintelligence.com/2013/01/03/whole-body-imaging-as-cancer-screening-tool-answering-an-unmet-clinical-need/

Article 11.3.6- https://pharmaceuticalintelligence.com/2013/02/03/state-of-the-art-in-oncologic-imaging-of-lymphoma/

Article 11.3.7- https://pharmaceuticalintelligence.com/2012/12/09/a-corner-in-the-medical-imagings-eco-system/

Article 11.4.1- https://pharmaceuticalintelligence.com/2013/05/18/causes-and-imaging-features-of-false-positives-and-false-negatives-on-18f-petct-in-oncologic-imaging/

Article 11.4.2- https://pharmaceuticalintelligence.com/2013/04/15/minimally-invasive-image-guided-therapy-for-inoperable-hepatocellular-carcinoma/

Article 11.4.3- https://pharmaceuticalintelligence.com/2013/01/14/improving-mammography-based-imaging-for-better-treatment-planning/

Article 11.4.4- https://pharmaceuticalintelligence.com/2012/11/04/closing-the-mammography-gap/

Article 11.4.5- https://pharmaceuticalintelligence.com/2013/01/23/state-of-the-art-in-oncologic-imaging-of-lungs/

Article 11.4.6- https://pharmaceuticalintelligence.com/2013/01/19/ovarian-cancer-and-fluorescence-guided-surgery-a-report/

Article 11.5.1- https://pharmaceuticalintelligence.com/2012/12/24/optical-coherent-tomography-emerging-technology-in-cancer-patient-management/

Article 11.5.2- https://pharmaceuticalintelligence.com/2013/01/09/new-imaging-device-bears-a-promise-for-better-quality-control-of-breast-cancer-lumpectomies-considering-the-cost-impact/

Article 11.5.3- https://pharmaceuticalintelligence.com/2013/03/03/virtual-biopsy-is-it-possible/

Article 11.5.4- https://pharmaceuticalintelligence.com/2013/02/22/new-envelopment-in-measuring-mechanical-properties-of-tissue/

18 June 2021

LPBI Phase 2: Proof of Concept – Cancer Volume 1 – Chapter 10 Completion

Dropbox– Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graphs and PPT

URL: https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Premalata%20Pati/Cancer%2C%20Vol%201%20Chapters%207-12/CHAPTER-10

WORD CLOUDs Uploaded in Articles of Chapter 10

Article 10.1- https://pharmaceuticalintelligence.com/2013/04/21/mesothelin-an-early-detection-biomarker-for-cancer-by-jack-andraka/

Article 10.2- https://pharmaceuticalintelligence.com/2012/12/25/stanniocalcin-a-cancer-biomarker/

Article 10.3- https://pharmaceuticalintelligence.com/2012/12/24/breast-cancer-genomic-profiling-to-predict-survival-combination-of-histopathology-and-gene-expression-analysis/

Article 10.4- https://pharmaceuticalintelligence.com/2012/10/24/biomarker-tool-development-for-early-diagnosis-of-pancreatic-cancer-van-andel-institute-and-emory-university/

Article 10.5- https://pharmaceuticalintelligence.com/2012/05/17/early-biomarker-for-pancreatic-cancer-identified/

Article 10.6- https://pharmaceuticalintelligence.com/2012/09/18/head-and-neck-cancer-studies-suggest-alternative-markers-more-prognostically-useful-than-hpv-dna-testing/

Article 10.7- https://pharmaceuticalintelligence.com/2013/05/29/opens-exome-service-for-rare-diseases-advanced-cancer-mayo-clinics-oncospire/

Article 10.8- https://pharmaceuticalintelligence.com/2013/05/23/in-search-of-clarity-on-prostate-cancer-screening-post-surgical-followup-and-prediction-of-long-term-remission/

LPBI Phase 2: Proof of Concept – Cancer Volume 1 – Chapter 9 Completion

Dropbox– Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graphs and PPT

URL: https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Premalata%20Pati/Cancer%2C%20Vol%201%20Chapters%207-12/CHAPTER-9

WORD CLOUDs Uploaded in Articles of Chapter 9

Article 9.1- https://pharmaceuticalintelligence.com/2013/05/21/early-detection-of-prostate-cancer-aua-guideline/

Article 9.2- https://pharmaceuticalintelligence.com/2013/05/20/testing-for-multiple-genetic-mutations-via-ngs-for-patients-very-strong-family-history-of-breast-ovarian-cancer-diagnosed-at-young-ages-negative-on-brca-test/

Article 9.3- https://pharmaceuticalintelligence.com/2013/05/16/a-blood-test-to-identify-aggressive-prostate-cancer-a-discovery-sri-international-menlo-park-ca/

Article 9.4- https://pharmaceuticalintelligence.com/2013/06/13/combining-nanotube-technology-and-genetically-engineered-antibodies-to-detect-prostate-cancer-biomarkers/

Article 9.5- https://pharmaceuticalintelligence.com/2012/09/23/warning-signs-may-lead-to-better-early-detection-of-ovarian-cancer/

Article 9.6- https://pharmaceuticalintelligence.com/2012/10/16/knowing-the-tumors-size-and-location-could-we-target-treatment-to-the-roi-by-applying-imaging-guided-intervention/

13 June 2021

LPBI Phase 2: Proof of Concept – Cancer Volume 1 – Chapter 8 Completion

Dropbox– Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graph and PPT

URL:

https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Premalata%20Pati/Cancer%2C%20Vol%201%20Chapters%207-12/CHAPTER-8

WORD CLOUDs Uploaded in Articles of Chapter 8

Article 8.1- https://pharmaceuticalintelligence.com/2013/05/21/prostate-cancer-molecular-diagnostic-market-the-players-are-sri-intl-genomic-health-wcleveland-clinic-myriad-genetics-wucsf-genomedx-and-biotheranostics/

Article 8.2- https://pharmaceuticalintelligence.com/2012/09/02/todays-fundamental-challenge-in-prostate-cancer-screening-2/

Article 8.3- https://pharmaceuticalintelligence.com/2012/07/31/prostate-cancers-plunged-after-uspstf-guidance-will-it-happen-again/

Article 8.4- https://pharmaceuticalintelligence.com/2012/05/27/new-prostate-cancer-screening-guidelines-face-a-tough-sell-study-suggests/

Article 8.5- https://pharmaceuticalintelligence.com/2012/12/01/diagnosing-lung-cancer-in-exhaled-breath-using-gold-nanoparticles/

11 June 2021

LPBI Phase 2: Proof of Concept – Cancer Volume 1 – Chapter 7 Completion

Dropbox– Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graph and PPT

URL: https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Premalata%20Pati/Cancer%2C%20Vol%201%20Chapters%207-12/CHAPTER-7

WORD CLOUDs Uploaded in Articles of Chapter 7

Article 7.1.1- https://pharmaceuticalintelligence.com/2013/01/12/harnessing-personalized-medicine-for-cancer-management-prospects-of-prevention-and-cure-opinions-of-cancer-scientific-leaders-httppharmaceuticalintelligence-com/

Article 7.1.2- https://pharmaceuticalintelligence.com/2012/11/20/personalized-medicine-based-cure-for-cancer-might-not-be-far-away/

Article 7.1.3- https://pharmaceuticalintelligence.com/2013/01/07/personalized-medicine-gearing-up-to-tackle-cancer/

Article 7.1.4- https://pharmaceuticalintelligence.com/2013/03/25/tel-aviv-sourasky-medical-center-cancer-prevention-center-excellent-example-for-adopting-prevention-of-cancer-as-a-mean-of-fighting-it/

Article 7.1.5- https://pharmaceuticalintelligence.com/2013/01/10/inspiration-from-dr-maureen-cronins-achievements-in-applying-genomic-sequencing-to-cancer-diagnostics/

Article 7.1.6- https://pharmaceuticalintelligence.com/2012/12/01/personalized-medicine-cancer-cell-biology-and-minimally-invasive-surgery-mis/

Article 7.2.1- https://pharmaceuticalintelligence.com/2012/10/29/cancer-genomics-leading-the-way-by-cancer-genomics-program-at-uc-santa-cruz/

Article 7.2.2- https://pharmaceuticalintelligence.com/2013/04/23/whole-exome-somatic-mutations-analysis-of-malignant-melanoma-contributes-to-the-development-of-personalized-cancer-therapy-for-this-disease/

Article 7.2.3- https://pharmaceuticalintelligence.com/2013/04/22/genotype-based-analysis-for-cancer-therapy-using-large-scale-data-modeling-nayoung-kim-phdc/

Article 7.2.4- https://pharmaceuticalintelligence.com/2013/04/21/cancer-genomic-precision-therapy-digitized-tumors-genome-wgsa-compared-with-genome-native-germ-line-flash-frozen-specimen-and-formalin-fixed-paraffin-embedded-specimen-needed/

Article 7.2.5- https://pharmaceuticalintelligence.com/2013/01/13/leaders-in-genome-sequencing-of-genetic-mutations-for-therapeutic-drug-selection-in-cancer-personalized-treatment-part-2/

Article 7.2.6- https://pharmaceuticalintelligence.com/2013/03/27/ethical-concerns-in-personalized-medicine-brca12-testing-in-minors-and-communication-of-breast-cancer-risk/

Article 7.3.1- https://pharmaceuticalintelligence.com/2013/05/09/the-development-of-sirna-based-therapies-for-cancer/

Article 7.3.2- https://pharmaceuticalintelligence.com/2012/10/26/mrna-interference-with-cancer-expression/

Article 7.3.3- https://pharmaceuticalintelligence.com/2013/05/07/cd47-target-therapy-for-cancer/

Article 7.3.4- https://pharmaceuticalintelligence.com/2013/04/06/targeting-mitochondrial-bound-hexokinase-for-cancer-therapy/

Article 7.3.5- https://pharmaceuticalintelligence.com/2012/11/14/gsk-for-personalized-medicine-using-cancer-drugs-needs-alacris-systems-biology-model-to-determine-the-in-silico-effect-of-the-inhibitor-in-its-virtual-clinical-trial/

Article 7.3.6- https://pharmaceuticalintelligence.com/2012/10/16/personalized-pancreatic-cancer-treatment-option/

Article 7.3.7- https://pharmaceuticalintelligence.com/2013/05/30/new-scheme-to-routinely-test-patients-for-inherited-cancer-genes/

Article 7.3.8- https://pharmaceuticalintelligence.com/2013/11/01/targeting-untargetable-proto-oncogenes/

Article 7.3.9- https://pharmaceuticalintelligence.com/2014/03/05/the-future-of-translational-medicine-with-smart-diagnostics-and-therapies-pharmacogenomics/#comment-54338

Article 7.4.1- https://pharmaceuticalintelligence.com/2013/05/25/personalized-medicine-and-colon-cancer/

Article 7.4.2- https://pharmaceuticalintelligence.com/2012/09/10/comprehensive-genomic-characterization-of-squamous-cell-lung-cancers/

Article 7.4.3- https://pharmaceuticalintelligence.com/2012/09/10/targeted-tumor-penetrating-sirna-nanocomplexes-for-credentialing-the-ovarian-cancer-oncogene-id4/

Article 7.4.4- https://pharmaceuticalintelligence.com/2012/06/19/cancer-and-bone-low-magnitude-vibrations-help-mitigate-bone-loss-5-2/

Article 7.4.5- https://pharmaceuticalintelligence.com/2012/05/27/new-prostate-cancer-screening-guidelines-face-a-tough-sell-study-suggests/

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to print (Opens in new window)
  • Click to email a link to a friend (Opens in new window)

Like this:

Like Loading...

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 9,459 other subscribers
  • Recent Posts

    • Creating a Twitter Space for @pharma_BI for Live Broadcasts March 14, 2023
    • The Vibrant Philly Biotech Scene: Recent Happenings & Deals March 11, 2023
    • Peak oxygen uptake (VO2peak) quantified fitness: Lifelong and late-onset athletes had higher VO2peak than non-athletes March 7, 2023
    • Merck’s sotatercept overachieves, PCSK9 inhibitor passes phase 2 March 6, 2023
    • Bacterial multidrug resistance problem solved by a broad-spectrum synthetic antibiotic March 1, 2023
    • Genetic variation causes human lupus, systemic lupus erythematosus (SLE) February 23, 2023
    • Mimicking vaginal cells and microbiome interactions on chip microfluidic culture February 14, 2023
    • Press Release for Five Bilingual BioMed e-Series in English and in Spanish January 29, 2023
    • 2022 FDA Drug Approval List, 2022 Biological Approvals and Approved Cellular and Gene Therapy Products January 17, 2023
    • Verily announced other organizational changes, 1/13/2023 January 16, 2023
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 Amandeep Kaur
    • 1 Aashir Awan, Phd
    • 1 Abhisar Anand
    • 1 Adina Hazan
    • 1 Alan F. Kaul, PharmD., MS, MBA, FCCP
    • 1 alexcrystal6
    • 1 anamikasarkar
    • 1 apreconasia
    • 1 aviralvatsa
    • 1 David Orchard-Webb, PhD
    • 1 danutdaagmailcom
    • 1 Demet Sag, Ph.D., CRA, GCP
    • 1 Dror Nir
    • 1 dsmolyar
    • 1 Ethan Coomber
    • 1 evelinacohn
    • 1 Gail S Thornton
    • 1 Irina Robu
    • 1 jayzmit48
    • 1 jdpmd
    • 1 jshertok
    • 1 kellyperlman
    • 1 Ed Kislauskis
    • 1 larryhbern
    • 1 Madison Davis
    • 1 marzankhan
    • 1 megbaker58
    • 1 ofermar2020
    • 1 Dr. Pati
    • 1 pkandala
    • 1 ritusaxena
    • 1 Rick Mandahl
    • 1 sjwilliamspa
    • 1 Srinivas Sriram
    • 1 stuartlpbi
    • 1 Dr. Sudipta Saha
    • 1 tildabarliya
    • 1 vaishnavee24
    • 1 zraviv06
    • 1 zs22

Powered by WordPress.com.

WPThemes.


%d bloggers like this: